Total Payments
$8,681
2023 Payments
$162.02
Companies
14
Transactions
128
Medicare Patients
1,326
Medicare Billing
$174,057
Payment Breakdown by Category
Education$4,000 (46.1%)
Food & Beverage$3,179 (36.6%)
Travel$1,502 (17.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $4,000 | 1 | 46.1% |
| Food and Beverage | $3,179 | 124 | 36.6% |
| Travel and Lodging | $1,502 | 3 | 17.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $5,773 | 10 | $0 (2017) |
| ORGANOGENESIS INC. | $1,527 | 55 | $0 (2021) |
| Smith+Nephew, Inc. | $586.02 | 45 | $0 (2021) |
| Endologix, LLC | $330.87 | 3 | $0 (2020) |
| Boston Scientific Corporation | $162.02 | 4 | $0 (2023) |
| Mallinckrodt LLC | $125.00 | 1 | $0 (2017) |
| Misonix Inc | $47.49 | 2 | $0 (2021) |
| Melinta Therapeutics, Inc. | $28.15 | 2 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $21.60 | 1 | $0 (2021) |
| KCI USA, Inc | $17.42 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $162.02 | 4 | Boston Scientific Corporation ($162.02) |
| 2022 | $15.69 | 1 | Aroa Biosurgery Incorporated ($15.69) |
| 2021 | $568.36 | 32 | ORGANOGENESIS INC. ($295.67) |
| 2020 | $313.73 | 14 | Endologix, LLC ($120.07) |
| 2019 | $583.23 | 25 | Organogenesis Inc. ($458.03) |
| 2018 | $496.89 | 23 | Organogenesis Inc. ($248.37) |
| 2017 | $6,541 | 29 | Intuitive Surgical, Inc. ($5,773) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $69.18 | General |
| Category: Upsylon_URO | ||||||
| 04/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.51 | General |
| Category: General - Female SUI_URO | ||||||
| 01/11/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $46.48 | General |
| Category: General - Female SUI_URO | ||||||
| 01/11/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: General - Female SUI_URO | ||||||
| 08/04/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| 09/28/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: Pharma Product | ||||||
| 09/23/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Pharma Product | ||||||
| 09/21/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: ANTIBIOTIC | ||||||
| 09/09/2021 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Wound Care | ||||||
| 09/09/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Pharma Product | ||||||
| 08/27/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: Wound Care | ||||||
| 08/12/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Pharma Product | ||||||
| 07/29/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Wound Care | ||||||
| 07/22/2021 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Wound Care | ||||||
| 07/01/2021 | ORGANOGENESIS INC. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $12.60 | General |
| Category: Wound Care | ||||||
| 07/01/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/29/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Wound Care | ||||||
| 06/24/2021 | Smith+Nephew, Inc. | GRAFIX (Medical Supply) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/24/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: Pharma Product | ||||||
| 06/11/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $27.42 | General |
| Category: Wound Care | ||||||
| 06/03/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Pharma Product | ||||||
| 05/13/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), REGRANEX, IODOSORB | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: Pharma Product | ||||||
| 05/07/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), REGRANEX, IODOSORB | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Pharma Product | ||||||
| 04/22/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $21.72 | General |
| Category: Wound Care | ||||||
| 04/22/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), REGRANEX, IODOSORB | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Pharma Product | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 614 | 1,101 | $256,242 | $86,390 |
| 2020 | 12 | 712 | 1,267 | $248,860 | $87,667 |
Total Patients
1,326
Total Services
2,368
Medicare Billing
$174,057
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 64 | 357 | $57,945 | $21,202 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 136 | $42,820 | $15,176 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 102 | 102 | $42,305 | $13,211 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 164 | $35,880 | $12,058 | 33.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $16,095 | $5,103 | 31.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 36 | 36 | $12,960 | $4,303 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 48 | $11,160 | $4,146 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 45 | $9,000 | $2,841 | 31.6% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 14 | 15 | $8,700 | $2,705 | 31.1% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 21 | 26 | $6,500 | $1,950 | 30.0% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 16 | 33 | $7,245 | $1,761 | 24.3% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2021 | 21 | 26 | $1,560 | $650.00 | 41.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 16 | 19 | $1,680 | $573.66 | 34.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $1,540 | $504.00 | 32.7% |
| 82565 | Blood creatinine level | Office | 2021 | 11 | 15 | $225.00 | $76.80 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 24 | $432.00 | $72.00 | 16.7% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2021 | 11 | 15 | $195.00 | $59.25 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 80 | 397 | $46,515 | $17,877 | 38.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 109 | 109 | $43,060 | $15,171 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 109 | 187 | $33,675 | $11,068 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 114 | $29,630 | $10,266 | 34.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 40 | $18,600 | $7,055 | 37.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 60 | 60 | $16,280 | $6,680 | 41.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 77 | $13,180 | $4,852 | 36.8% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2020 | 25 | 65 | $13,000 | $3,558 | 27.4% |
About Dr. John Hordines, M.D
Dr. John Hordines, M.D is a Vascular Surgery healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891894853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hordines, M.D has received a total of $8,681 in payments from pharmaceutical and medical device companies, with $162.02 received in 2023. These payments were reported across 128 transactions from 14 companies. The most common payment nature is "Education" ($4,000).
As a Medicare-enrolled provider, Hordines has provided services to 1,326 Medicare beneficiaries, totaling 2,368 services with total Medicare billing of $174,057. Data is available for 2 years (2020–2021), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular Surgery
- Location Newburgh, NY
- Active Since 09/22/2006
- Last Updated 09/18/2020
- Taxonomy Code 2086S0129X
- Entity Type Individual
- NPI Number 1891894853
Products in Payments
- Da Vinci Surgical System (Device) $5,773
- Apligraf (Device) $644.41
- Apligraf (Biological) $501.98
- Santyl (Drug) $296.72
- Ovation (Device) $231.26
- Puraply Antimicrobial (Medical Supply) $216.65
- COLLAGENASE SANTYL (Drug) $188.30
- Puraply (Medical Supply) $164.19
- OFIRMEV (Drug) $125.00
- Upsylon (Device) $69.18
- Grafix PL PRIME (Biological) $39.14
- GRAFIX PL (Biological) $29.84
- Baxdela (Drug) $28.15
- NUZYRA (Drug) $21.60
- SNAP (Device) $17.42
- AQUACEL Ag Advantage Surgical (Device) $16.79
- SIVEXTRO (Drug) $15.99
- Omnigraft (Device) $13.75
- GRAFIX PL (Medical Supply) $11.36
- PICO (Device) $10.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.